| Principal Investigator
| Grant Title
| Total Amount Awarded
| Comments
|
|
| André M. Cantin
| Alpha1-antitrypsin and albumin in cystic fibrosis
| $131,000.00
| 2 year award
|
| Paul Kubes
| The anti-inflammatory effects of Antithrombin III (AT III) in ischemia/repercussion injury
| $140,000.00
| 2 year award
|
| David Lillicrap
| Strategies to enhance the development of a Gene Therapy approach to Hemophilia A
| $172,756.00
| 2 year award
|
| Catherine Bergeron
| Lesion Profiling and glycoform analysis in Creutzfeldt-Jakob disease (CJD)
| $42,000.00
| 1 year award
|
| John W. Semple
| In vivo effects of IVIG prepared from multiparous sera (IVIG MP) on modulating recipient alloimmunity
| $157,000.00
| 2 year award
|
| David Westaway
| A transgenic approach to the molecular biology of Creutzfeldt-Jakob disease
| $160,000.00
| 2 year award
|
| Thomas Ming Swi Chang
| Request for Renewal of Grant 9622R – Biodegradable Polymeric Hemoglobin Nanocapsules as a Blood Substitute
| $85,000.00
| 1 year award
|
| Alan H. Lazarus
| Request for Renewal of Grant 9911 – Analysis of monoclonal human IVIG using a passive murine model of idiopathic thrombocytopenic purpura (ITP)
| $160,000.00
| 2 year award
|
| Jean-François Hardy
| Treatment of Heparin Resistance with Antithrombin Concentrate in Patients Undergoing Myocardial Revascularization with Cardiopulmonary Bypass
| $59,000.00
| 1 year award
|
| Ian D. Dubé
| Request for Renewal – Molecular genetic characterization of the inductive hematopoietic microenvironment
| $80,000.00
| 1 year award
|
| Ori D. Rotstein
| Preconditioning using 25% Albumin: A Novel Method for Organ Protection in Ischemia-Reperfusion Injury
| $70,000.00
| 1 year award
|
| Yu-Wen Hu
| The clinical consequence of high frequency of TT virus infection and re-infection in vulnerable blood transfusion or blood product dependent patients
| $80,000.00
| 1 year award
|
| Donna A Chow
| IVIG Regulation of T Cell Activation
| $70,000.00
| 1 year award
|
| Peter J. O’Brien
| Donor blood for cardiac surgery: hemebinding proteins may protect the heart
| $50,000.00
| 1 year award
|
| Elisabeth Maurer-Spurej
| Heat shock treatment may induce stress tolerance in platelets for improved quality of platelet concentrates
| $45,000.00
| 1 year award
|
| Gail A. Rock
| A study of the effects of using cryosupernatant plasma versus fresh frozen plasma as replacement fluid in plasma exchange for thrombotic thrombocytopenic purpura
| $25,000.00
| 1 year award
|
| Sonia Néron
| Regulation of B lymphocyte functions by intravenous immunoglobulins (IVIG)
| $60,000.00
| 1 year award
|
| Renée Bazin
| Study of the mechanism of action of intravenous immunoglobulin (IVIG) in an animal model
| $78,000.00
| 1 year award
|
| Bruce Mazer
| Regulation of immune activation by intravenous immunoglobulin: Characterization of B lymphocyte activation, maturation and cytokine response
| $52,326.00
| 1 year award
|
| Valery Leytin
| Optimization of dose for platelet transfusion: Adjustment in accordance with quality of platelets
| $76,000.00
| 1 year award
|
| Eveline de Médicis
| Novel regulatory genes of erythropoiesis
| $140,000.00
| 2 year award
|